Systemic cause of unstable atherosclerotic plaques. Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque (ATROCAP) study group. | CureHunter

HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Systemic cause of unstable atherosclerotic plaques. Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque (ATROCAP) study group.

Authors	M Cortellaro, E Cofrancesco, E Arbustini, L Gabrielli, E Tremoli
Journal	Lancet (London, England) (Lancet) Vol. 355 Issue 9212 Pg. 1362-3; author reply 1363-4 (Apr 15 2000) ISSN: 0140-6736 [Print] England
PMID	10776765 (Publication Type: Letter, Comment)
Chemical References	Anticholesteremic Agents Heptanoic Acids Pyrroles Atorvastatin
Topics	Anticholesteremic Agents (therapeutic use) Arteriosclerosis (drug therapy, etiology, mortality) Atorvastatin Carotid Stenosis (drug therapy, etiology, mortality) Cause of Death Heptanoic Acids (therapeutic use) Humans Pyrroles (therapeutic use) Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!